Top Story

Stimulant medications determined safe for children with ADHD, heart disease

October 7, 2015

Children with attention-deficit/hyperactivity disorder and congenital heart disease can use stimulant medications without facing potential cardiovascular side effects, according to study results presented at the annual meeting of the Society for Developmental and Behavioral Pediatrics in Las Vegas.

“Children with congenital heart disease are at high risk for ADHD, but fears about cardiovascular side effects, including sudden death, limit the use of stimulant medications,” Julia Anixt, MD, a developmental and behavioral pediatrician at Cincinnati Children’s Hospital, said in a press release.

Julia Anixt, MD

Julia Anixt

Barbara A. Cohn, PhD In the Journals

Pregnancy complications may predict later-life CVD death

October 7, 2015
Multiple pregnancy complications may predict heightened risk for CVD death later in life and identify women needing early intervention efforts, according recent data in…
Derek J. Hausenloy, PhD, FRCP, FACC, FESC In the Journals

Remote ischemic preconditioning does not improve cardiac surgery outcomes

October 7, 2015
Remote ischemic preconditioning failed to improve clinical outcomes after elective cardiac surgery, according to two studies published in The New England Journal of
FDA News

Robotic-assisted PCI system cleared for transradial access procedures

October 7, 2015
Corindus Vascular Robotics announced that its robotic-assisted PCI system has received 510(k) clearance from the FDA for use in PCI procedures performed via transradial…
In the Journals

New guideline focuses on management of adults with supraventricular tachycardia

October 7, 2015
The American College of Cardiology, American Heart Association and Heart Rhythm Society have released a guideline on best practices for management of adults with…
More News Headlines »
Cardiology Case Consults

The Patient With Severe Hypertriglyceridemia

No commercial support for this activity.

Elevated serum triglycerides are a highly prevalent yet modifiable risk factor for atherosclerotic disease and its…
More »
Meeting News Coverage Video
VIDEO: Expert discusses future of hyperkalemia management in patients with HF

VIDEO: Expert discusses future of hyperkalemia management in patients with HF

September 28, 2015
NATIONAL HARBOR, Md. — In this video, Javed Butler, MD, chief of cardiology and co-director of the Heart…
More »
J832 Activity Image 4

Antiplatelet Agents for Secondary Prevention of Thrombotic Cardiovascular Events in Patients with History of Peripheral Arterial Disease

This activity is supported by an educational grant from Merck & Co., Inc.

In this CME activity, Dr. Mark Bonaca discusses the use of antiplatelet agents for secondary prevention of thrombotic…
More »